Table 3.
Univariate and multivariate analyses for DSS in the training set.
Variable | Training set |
||
---|---|---|---|
Univariate analysis |
Multivariate analysis |
||
p-value | HR (95% CI) | p-value | |
Age (≤60/>60) | <0.001a | 1.89 (1.17–3.05) | 0.009a |
Sex (female/male) | 0.187 | ||
T stage (Ⅰ/Ⅱ/Ⅲ/Ⅳ) | <0.001a | 1.80 (1.37–2.35) | <0.001a |
Necrosis (no/yes) | <0.001a | 2.69 (1.61–4.48) | <0.001a |
Lymph node involvement (no/yes) | <0.001a | 5.53 (2.47–12.38) | <0.001a |
Sarcomatoid differentiation (no/yes) | <0.001a | 4.52 (2.23–9.16) | <0.001a |
CID (<50%/≥50%) | <0.001a | 10.78 (6.63–17.53) | <0.001a |
Tumor size, cm (4≤/4–7/>7) | <0.001a |
DSS, disease-specific survival; HR, hazard ratio; CI, confidence interval; CID, contour irregularity degree.
Indicate statistical significance.